Wir freuen uns über den @houskapreis für die Entwicklung von zwei CE-zertifizierten quantitativen #SARSCoV2-Antikörpertests! Gemeinsam mit @bokuvienna, @univienna und @vetmedunivienna wurde eine österreichische Erfolgsgeschichte geschrieben. Alle Details: https://t.co/PANkpN5Yhp
@florianklenk Puh - echt schwierig. Für mich kann ich nur eines feststellen: Wer sich hier zu einem Urteil hinreißen lässt, liegt ganz bestimmt falsch.
@OdedRechavi I once ordered „Cuban beard“ in a place at the Florida Keys besides other dishes. Was pretty excited since this sounded a little awkward. Turned out it was a typo in the menu, was just Cuban bread (boring). Up to now I still wonder what a dish named Cuban beard could look like.
As a Board Member, I’m excited to see Transplant International @Transpl_Int, the official journal of @ESOTtransplant, transition to Gold OA in partnership with @FrontiersIn. Find out more: https://t.co/22WxRzdBxI
meet the TTVguideIT consortium 🇪🇺@MarietFeltkamp@puchhammer@biomerieux at the virtual @ESCVirology congress 15.-17.9. wirh new data on torque teno 🦠 for diagnosis of kidney transplant rejection and infection;https://t.co/cb3IzbIuP0
ich finde die menschen, die sich auf die medizinischen meinungen von til schweiger und nina proll verlassen, sollten sich bei einem schweren covid verlauf auch von til schweiger und nina proll behandeln lassen.
@AaronGoodman33 @VPrasadMDMPH@ManniMD1 I like you guys, you are so refreshingly honest about what’s happening in academic hematology/oncology, even though it’s not my specialty. But this kind of communication helps waking up other critical minds in other disciplines too.
Sat down with the great @AaronGoodman33 and Chris Booth to discuss their new paper
Practicing at the edge of oncology
Fans of @Plenary_Session won't want to miss it
https://t.co/W4XA6B6EIN
Salt substitute really worked well to reduce major cardiovascular events in a large randomized trial conducted in China
@NEJM today #ESCCongress2021
https://t.co/2VJcguFHdA
very relevant findings: use of VKA in HD patients with AF was associated with net-clinical harm (adjusted SHR 2.07 95%CI 1.25–3.42); thanks to @Cihan_Ay_MD an his team